Market Overview The Mexico Growth Hormone Deficiency Clinical Trials Market was valued at USD 98 million in 2023 and is projected to grow at a CAGR of 4.9% from 2024 to 2030, reaching nearly USD 136.98 million by 2030. The market is benefiting from increasing clinical research activities, growing awareness of growth hormone deficiency (GHD), improvements in...